Caris Life Sciences, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Caris Life Sciences, Inc. on September 14, 2026. The filing serves as a Regulation FD disclosure regarding the Company's intent to utilize a new investor presentation at the Morgan Stanley 24th Annual Global Healthcare Conference and other investor meetings.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure of forward-looking communication materials rather than a financial results report.
Material Changes
No material changes to financial performance or operations are reported in this filing. The only change noted is the commencement of the use of a specific investor presentation for investor relations activities.
Guidance, Outlook, and Risks
The Company intends to use the "Investor Presentation" to communicate with current and potential investors. The presentation will be posted on the Company's investor relations website. The filing explicitly states that the website and presentation contents are not incorporated into this Current Report and are not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the content of the Investor Presentation posted on the Company's investor relations website.
- Confirm the date and details of the Morgan Stanley 24th Annual Global Healthcare Conference.
- Note that the information in this 8-K is not incorporated by reference into other filings unless expressly stated.